On November 11, Shanghai Medicilon Inc. (688202) announced that shareholder Lin Changqing reduced his stake in the company by a total of 1.54 million shares, accounting for 1.15% of the company's total shares, through centralized bidding and block trades.
In the first three quarters of 2025, Shanghai Medicilon Inc. reported revenue of 843 million yuan, with a net loss attributable to shareholders of 29.68 million yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments